EVOKE PHARMA INC's ticker is and the CUSIP is 30049G203. A total of 12 filers reported holding EVOKE PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 3,985 | $8 | 0.00% |
| Concord Wealth Partners | 114 | $217 | 0.00% |
| Renaissance Technologies | 11,178 | $21 | 0.00% |
| ROYAL BANK OF CANADA | 28 | $0 | 0.00% |
| VANGUARD GROUP INC | 29,851 | $56,717 | 0.00% |
| UBS Group AG | 1,107 | $2,103 | 0.00% |
| NewEdge Advisors, LLC | 208 | $395 | 0.00% |
| WELLS FARGO & COMPANY/MN | 16 | $30 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 20,894 | $39,698 | 0.00% |
| BlackRock Inc. | 1,473 | $2,799 | 0.00% |
| Lindbrook Capital, LLC | 83 | $158 | 0.00% |
This page lists EVOKE PHARMA INC's shareholders in Q1 2023. To view EVOKE PHARMA INC's shareholder history, click here.